Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals

Broadly Cross clade Neutralizing (BCN) antibodies are recognized as potential therapeutic tools and leads for the design of a vaccine that can protect human beings against various clades of Human Immunodeficiency Virus (HIV). In the present study, we screened plasma of 88 HIV-1 infected ART naïve in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheedarla, Narayanaiah, Precilla, K. Lucia, Babu, Hemalatha, Vijayan, K. K. Vidya, Ashokkumar, Manickam, Chandrasekaran, Padmapriyadarsini, Kailasam, Nandagopal, Sundaramurthi, Jagadish Chandrabose, Swaminathan, Soumya, Buddolla, Viswanath, Vaniambadi, S. Kalyanaraman, Ramanathan, V. D., Hanna, Luke Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402285/
https://www.ncbi.nlm.nih.gov/pubmed/28436427
http://dx.doi.org/10.1038/srep46557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402285/
https://www.ncbi.nlm.nih.gov/pubmed/28436427
http://dx.doi.org/10.1038/srep46557

Ejemplares similares